Simplex Trading
CUE icon

Simplex Trading’s Cue Biopharma CUE Stock Holding History

Simplex Trading’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-113
Closed -$3K – 8682
2024
Q4 		$3K Buy
+113
New +$4.25K ﹤0.01% 7857
2024
Q3 		– Sell
-2,937
Closed -$109K – 8649
2024
Q2 		$109K Buy
2,937
+1,544
+111% +$76.4K ﹤0.01% 5289
2024
Q1 		$79K Sell
1,393
-2,834
-67% -$200K ﹤0.01% 5826
2023
Q4 		$334K Buy
4,227
+2,570
+155% +$184K ﹤0.01% 4105
2023
Q3 		$114K Sell
1,657
-2,513
-60% -$245K ﹤0.01% 4951
2023
Q2 		$456K Buy
4,170
+3,477
+502% +$409K ﹤0.01% 3409
2023
Q1 		$74K Sell
693
-177
-20% -$16.9K ﹤0.01% 5491
2022
Q4 		$74K Buy
870
+733
+535% +$67K ﹤0.01% 5410
2022
Q3 		$9K Sell
137
-250
-65% -$21.5K ﹤0.01% 8304
2022
Q2 		$28K Sell
387
-806
-68% -$94.3K ﹤0.01% 7215
2022
Q1 		$174K Buy
1,193
+1,100
+1,183% +$233K ﹤0.01% 5346
2021
Q4 		$31K Sell
93
-414
-82% -$160K ﹤0.01% 7852
2021
Q3 		$186K Buy
507
+17
+3% +$5.93K ﹤0.01% 5712
2021
Q2 		$171K Buy
490
+489
+48,900% +$190K ﹤0.01% 5937
2021
Q1 		$25K Buy
+1
New +$412 ﹤0.01% 7264
2020
Q4 		– Hold
0
– – – 7957
2020
Q3 		– Hold
0
– – – 7530
2020
Q2 		– Hold
0
– – – 6070

Other funds holding CUE

BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return
SC
Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM

Simplex Trading's CUE Position: Q2 2026 in Review

Simplex Trading sold out of Cue Biopharma (CUE) in Q2 2026, closing a stake of 29 shares — an estimated $201 sold.

Simplex Trading first reported a position in CUE in Q1 2020 and held it in 18 quarters. The position peaked at $130K in Q4 2021. 49 funds tracked by Wall St. Rank hold CUE as of Q2 2026.

  • Simplex Trading reported no remaining Cue Biopharma position as of Q2 2026 after selling out during the quarter.
  • Simplex Trading sold 29 Cue Biopharma shares in Q2 2026, an estimated $201.
  • Simplex Trading first reported a position in Cue Biopharma in Q1 2020 and held it in 18 quarters.
  • Simplex Trading's Cue Biopharma position peaked at $130K in Q4 2021.
  • 49 funds tracked by Wall St. Rank held Cue Biopharma as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.